Advertisement

Topics

Companies Related to "Statin Therapy Reduces Risk Diabetic Retinopathy T2DM" [Most Relevant Company Matches] [Advanced Search Results] RSS

19:58 EDT 25th March 2019 | BioPortfolio

Here are the most relevant search results for "Statin Therapy Reduces Risk Diabetic Retinopathy T2DM" found in our extensive corporate database of over 50,000 company records.

Showing "Statin Therapy Reduces Risk Diabetic Retinopathy T2DM" Companies 1–25 of 2,300+

Extremely Relevant

Eyenuk Inc.

Eyenuk Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk’s first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology...


VisionQuest Biomedical LLC

VisionQuest Biomedical is a research and development (R&D) company based in Albuquerque, NM. VisionQuest uses artificial intelligence to detect multiple ophthalmic conditions, such as diabetic retinopathy and malarial retinopathy.

Imposter Research

IMPOSTER is the name of a medical research study of patients with muscle symptoms while taking cholesterol lowering therapies called statins. Several important findings from this study have been published and have raised questions about the safety of statin therapy for patients with muscle complaints. This website was developed to address those questions and to share what is known about statin mu...


Relevant

Allegro Ophthalmics, LLC

With more than 100 years of combined experience in vision science and medicine, the leadership team at Allegro Ophthalmics, LLC is establishing Integrin Peptide Therapy as the next-generation pharmaceutical category for the treatment of wet age-related macular degeneration, diabetic retinopathy and diabetic macular edema, which together affect nearly si...

Georgia Retina, P.C.

The physicians of Georgia Retina specialize in the diagnosis and treatment of diabetic retinopathy, macular pucker and macular holes, age-related macular degeneration, retinal detachment, proliferative vitreoretinopathy, ocular trauma, hereditary macular disease, retinopathy of prematurity and other forms of retinal and vitreous pathologies.

Eyenuk, Inc.

Eyenuk, Inc., headquartered in Los Angeles, California, is an AI diagnostic company focused on quickly and accurately identifying patients suffering from potentially blinding eye diseases and chronic diseases at the point of care. Using computer vision and machine learning expertise, the company is developing a portfolio of products based on its proprietar...

Kubota Pharmaceutical Holdings Co., Ltd.

Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596) is committed to translating innovation into a diverse portfolio of drugs and devices to preserve and restore vision for millions of people worldwide. The company’s development pipeline includes drug candidates and therapeutics for the treatment of retinitis pigmentosa, proliferative diabetic retino...

Acucela Inc.

Acucela Inc. is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for treating blinding eye diseases that affect tens of millions of people worldwide. The company’s orally-delivered VCM therapies, which selectively target cells within the retina to protect visual acui...

Doctor Diabetic Supply, Inc.

Doctor Diabetic Supply, Inc. is a medical supply distribution company headquartered in Miami, FL. Doctor Diabetic Supply employs over 260 people and serves more than 80,000 customers nationwide. The company is a leading direct-to-consumer provider of diabetic testing supplies and related products. Founded in 2001, Doctor Diabetic Supply, Inc. has grown to be one of the largest diabetic supply comp...

Aerpio Pharmaceuticals, Inc.

Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The Company’s lead program, AKB‐9778, is a small molecule activator of the Tie2 pathway and is in clinical development for diabetic retinopathy.

Lumigent Technologies, Inc.

Lumigent reduces the cost of auditing and compliance reporting with automated Governance, Risk and Compliance software. Lumigent’s AppGRC® reduces cost and mitigates risk by continuously monitoring application specific data and controls, ensuring the integrity of critical business information. Organizations worldwide use Lumigent’s AppGRC soft...

Acucela

Acucela Inc. (www.acucela.com) is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for treating blinding eye diseases that affect tens of millions of people worldwide. The Company’s orally delivered VCM compounds, which selectively target cells within the retina to p...

Diamyd Medical AB (publ)

The purpose of the GAD65-based diabetes therapy Diamyd(R) is to prevent, delay, or stop the autoimmune attack on beta cells in type 1 diabetes and other forms of autoimmune diabetes, thereby preserving the body's capacity to regulate blood sugar. This reduces the risk for both acute and long term diabetes complications significantly.

Promedior, Inc.

Promedior has developed a novel drug discovery platform to regulate the monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases. By specifically targeting these cells at the site of injury, Promedior is able to treat the source of aberrant immune system responses, promote tissue healing and resolution, and gr...

Alteon Incorporated

Alteon is engaged in the discovery and development of pharmaceutical products for the treatment of the complications of diabetes and age-related diseases. Alteon's efforts have focused primarily on developing its lead first-in-class compound, pimagedine, as an agent to inhibit or block abnormal glucose/protein complexes, known as Advanced Glycosylation End-products ("A.G.E.s"), that lead to diabet...

BioStratum Incorporated

BioStratum is focused on the discovery, development and commercialization of novel therapeutic agents for the treatment of diabetes and diabetic complications. BioStratum's pipeline is led by Pyridorin™ a small molecule drug for the treatment of diabetic kidney disease, followed by pre-clinical compounds that will treat other diabetic complications and cancer. Pyridorin has been granted Fast Tra...

OcuSciences, Inc.

OcuSciences, Inc., is a clinical-stage biotechnology company developing retinal imagers to identify metabolic dysfunction occurring in the retina for the detection of early disease. Its flagship device, the OcuMet Beacon, is being developed to automatically and non-invasively assess retinal metabolic function by detecting the degree of flavoprotein fluores...

Diabetic Care Services & Pharmacy

Headquartered in Cleveland, Ohio Diabetic Care Services & Pharmacy is one of the nation’s leading mail-order providers of durable medical equipment supplies and prescription medications for diabetes customers and related conditions. For Medicare and private insurance customers, Diabetic Care Services & Pharmacy delivers one-stop shopping, 24/7 persona...

NormOxys, Inc.

NormOxys is developing a novel class of small molecule drugs, oxyrens, which enhance the body’s ability to deliver oxygen more efficiently to diseased tissues with oxygen deficiency. This new class of drugs can be potentially developed in a broad range of clinical indications where therapeutic benefit can be obtained through an increased, regulated de...

ProCure Treatment Centers, Inc.

ProCure Treatment Centers, Inc. is a privately held healthcare company dedicated to improving the lives of patients with cancer by increasing access to proton therapy. The company was founded in 2005 in Bloomington, Ind., and is the first to develop a network of proton therapy centers in cities across the United States. The ProCure Proton Therapy Center in...

Optos plc

Optos plc is a leading medical retinal imaging technology company. Both eye and non-eye diseases often first exhibit in the periphery of the retina. These are very difficult to detect clinically with conventional examination equipment and techniques. Optos' devices produce ultra wide-field, high-resolution images of approximately 82% of the retina, somethi...

Altris.AI

Altris.AI (Altris, Inc) is a company which applies computer vision and deep learning trained algorithms to build innovative ophthalmology diagnosis real-time support platform for the automatic, structural and quantitative analysis and detection of glaucoma, age-related macular degeneration, diabetic retinopathy and other retinal diseases on Optical Coheren...

Interleukin Genetics

Interleukin Genetics aims to be the world leader in understanding the genetics of inflammation, one of the body's most important defense mechanisms. Our scientists and clinicians study how common variations in several genes, especially three (known as IL-1a, IL-1b, and IL-1RN) affect an individual's response to the injuries caused by chronic diseases or disabilities such as coronary artery disease...

Bellingham Regional Breast Center

The Bellingham Regional Breast Center provides comprehensive diagnosis and treatment for all breast disorders. Services include early diagnosis; risk analysis with genetic counseling and testing; treatment with surgery, radiation therapy, chemotherapy, endocrine therapy, targeted therapies, and immune therapy; and supportive care including counseling, phys...

Galaxy Pharma (Pvt) Limited

Welcome at Galaxy Pharma (Pvt) Limited. The company having the objective of serving the patients with the most developed and innovative brands. If you wish to visit our Corporate Web Site, then kindly CLICK on the LINK ABOVE. Galaxy Pharma (Pvt) Limited is specialising in the following key areas: 1 - Anti-Diabetic 2 - Female & Male Harmones 3 - Diabetic Neuropathy 4 - Muscle & Bone Diorders


More From BioPortfolio on "Statin Therapy Reduces Risk Diabetic Retinopathy T2DM"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks